z-logo
open-access-imgOpen Access
Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
Author(s) -
Zhenyu Zhong,
Elsa SánchezLópez,
Michael Karin
Publication year - 2016
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2016.05.051
Subject(s) - autophagy , immunosurveillance , biology , immunity , inflammation , immunogenic cell death , cancer , antigen presentation , cancer research , cancer immunotherapy , immunotherapy , acquired immune system , cancer cell , immunology , immune system , apoptosis , t cell , biochemistry , genetics
Autophagy, a cellular waste disposal process, has well-established tumor-suppressive properties. New studies indicate that, in addition to its cell-autonomous anti-tumorigenic functions, autophagy inhibits cancer development by orchestrating inflammation and immunity. While attenuating tumor-promoting inflammation, autophagy enhances the processing and presentation of tumor antigens and thereby stimulates anti-tumor immunity. Although cancer cells can escape immunosurveillance by tuning down autophagy, certain chemotherapeutic agents with immunogenic properties may enhance anti-tumor immunity by inducing autophagic cell death. Understanding the intricate and complex relationships within this troika and how they are affected by autophagy enhancing drugs should improve the efficacy of cancer immunotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom